logo
Plus   Neg
Share
Email

FDA Grants Priority Review For Novartis' Sickle Cell Medicine Crizanlizumab

Novartis (NVS) said Tuesday that the US Food and Drug Administration accepted the company's Biologics License Application or BLA and granted Priority Review for its investigational sickle cell medicine crizanlizumab or SEG101.

If FDA-approved, crizanlizumab is expected to represent the first monoclonal antibody targeting the P-selectin mediated multi-cellular adhesion in sickle cell disease.

Sickle cell disease is a debilitating inherited genetic blood disorder that affects the shape of the red blood cells and can make blood cells and blood vessels stickier than usual.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Krispy Kreme Doughnuts is giving a dozen of its Original Glazed Doughnuts for just $1 as part of its annual 'Day of the Dozens' offer. The offer is available on Thursday, December 12, and is a play on the date, 12/12. To get the deal, customers have to purchase a dozen doughnuts at the store's retail price. Customers can buy doughnuts of any flavor they like to qualify for the deal. Home Depot has blamed the nation's opioid crisis for the recent surge in theft at its stores, reports said. The home improvement retailer made the claim at an analyst and investor conference on Wednesday saying it expects the theft, which retailers call shrink, to narrow its operating margin for the next year. The opioid crisis in the U.S. is growing at an alarming rate. Amazon said that Prime members in select areas can shop a number of items until Christmas Eve and receive them on the same day itself with Prime free same-day delivery and free two-hour delivery. The option is available through Amazon Fresh and Whole Foods Market. In addition to groceries, Prime members in select cities can shop Amazon Fresh for tens of thousands of items.
Follow RTT
>